M. Montes

发表

All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice: Madrid coinfection registry findings

J. Losa, P. Ryan, C. Barros, 2018, Hepatology.

Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens

J. Arribas, M. Abadia, A. Olveira, 2022, Open forum infectious diseases.

Discovering HIV related information by means of association rules and machine learning

Miguel Ángel Martínez, Juan Martínez-Romo, Lourdes Araujo, 2022, Scientific Reports.

Acute hepatitis B among HIV positive persons: A two-decade review of cases from a Spanish cohort.

J. Arribas, V. Moreno, R. Montejano, 2022, Enfermedades infecciosas y microbiologia clinica.

Acute hepatitis B among HIV positive persons: A two-decade review of cases from a Spanish cohort.

J. Arribas, V. Moreno, R. Montejano, 2020, Enfermedades infecciosas y microbiologia clinica.

Pegylated interferon a 2 a plus ribavirin versus pegylated interferon a 2 b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

C. Tural, J. Mallolas, C. Quereda, 2009 .

Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses.

S. Lewin, K. Ruxrungtham, D. Boulware, 2013, The Journal of infectious diseases.

Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.

C. Tural, J. Mallolas, C. Quereda, 2009, The Journal of antimicrobial chemotherapy.

Pegylated interferon a 2a plus ribavirin versus pegylated interferon a 2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

C. Tural, J. Mallolas, C. Quereda, 2009 .

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

I. Martínez, M. Salavert, E. Ribera, 2019, Scientific Reports.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Efficacy and tolerability of telaprevir (TVR)-based triple therapy in HIV/HCV-coinfected patients

L. Perez-Caballero, G. Gaspar, J. Sanz-Moreno, 2014, Journal of the International AIDS Society.

Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis

A. Horban, S. Ouwerkerk-Mahadevan, J. Sasadeusz, 2014, Journal of the International AIDS Society.

Safe coadministration of raltegravir-based HAART in HIV-infected patients with HCV-cirrhosis receiving triple therapy with telaprevir or boceprevir.

C. Quereda, S. Moreno, M. Pérez-Elías, 2012, Journal of acquired immune deficiency syndromes.

Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.

C. Tural, J. Mallolas, M. Crespo, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of Sustained Viral Response in Patients With HIV and Chronic Hepatitis C and Nonadvanced Liver Fibrosis

M. Crespo, C. Quereda, J. Bellón, 2014, Journal of acquired immune deficiency syndromes.

Prevalence of non-alcoholic fatty liver disease in a multicentre cohort of people living with HIV in Spain.

J. Navarro, A. Curran, J. Burgos, 2023, European journal of internal medicine.

Abacavir/lamivudine + unboosted atazanavir in routine clinical practice: Twelve years experience.

V. Moreno, R. Montejano, L. Martín-Carbonero, 2018, Enfermedades Infecciosas y Microbiologia Clinica.

PREVALENCE AND TEMPORAL TRENDS OF AUTOIMMUNE DISEASES IN PEOPLE LIVING WITH HIV.

M. Díaz-Almirón, R. Montejano, L. Martín-Carbonero, 2023, AIDS research and human retroviruses.

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DU

D. Podzamczer, B. Clotet, E. Negredo, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study.

A. Cruceta, J. Mallolas, M. Laguno, 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients.

M. Crespo, C. Quereda, J. Bellón, 2015, Annals of hepatology.

Association of baseline CD 4 + cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV / HCV coinfected patients

M. Crespo, C. Quereda, J. Bellón, 2015 .

Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119

J. De La Torre, E. Ribera, R. Palacios, 2023, HIV medicine.